Ingelheim, Germany Saturday, January 18, 2025, 11:00 Hrs [IST] ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...

The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion ...

Hill’s Pet Nutrition is sponsoring the VMX Sunday Spectacular so join them in the Expo Hall at the VMX Main Stage from 7:30 to 9:30 PM Sunday, January 26, 2025, to see Acrobatic Art with HeART, a ...

All of this has spurred the agriculture and animal health industries into ... Companies, including Boehringer Ingelheim, are working in collaboration with USDA and the broader livestock industry ...

Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for its animal health business Merial – the latest in a trend for multi-billion swaps in big pharma. The deal ...

“Only about two large pharmaceutical companies still have an animal health business,” he said. “Those are the US Merck or MSD and Boehringer Ingelheim. All the other companies, whether it ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...